Edison was a partner of the 3rd Annual Nordic-American Life Science conference, which took place in New York on 28–29 November. Organised by DNB, Nasdaq and Business Sweden, the conference saw a gathering of management teams from biotech, medtech and diagnostics companies from Sweden, Norway, Finland and Denmark presenting to and meeting North American investors. Edison clients presenting were Herantis, Orexo, Targovax and Xbrane. Panel sessions discussed the challenges of bringing promising and innovative life science technology to the US market, discussing topics such as company funding, drug pricing, the US regulatory system and forming effective boards. Of the many areas covered, one that stood out for us was antimicrobial resistance and healthcare-associated infections as articulated by Bactiguard.